🔗 Permalink

Inventor profile of:

Mark G. Erlander

City:

Carlsbad, California

Country:

United States

Published Applications:

Last publication date:

2026-05-07

Top Assignees for applications by Mark G. Erlander

The entities that hold a legal rights for patent applications filed by inventor Erlander Mark G.:

BIOTHERANOSTICS, INC. 11 San Diego, CA United States
The General Hospital Corporation 5 Boston, MA United States
LIFE TECHNOLOGIES CORPORATION 3 Carlsbad, CA United States
bio Theranostics, Inc. 1 San Diego, CA United States
Trovagene, Inc. 1 San Diego, CA United States
MDS Analytical Technologies Inc. (US) 1 Sunnyvale, CA United States
GENERAL HOSPITAL CORPORATION 1 Boston, MA United States

Recent patent applications by Erlander Mark G.

Mark G. Erlander from Carlsbad, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-07

US20260125764A1

Chemistry; metallurgy

POST-TREATMENT BREAST CANCER PROGNOSIS

#2 | 2022-06-16

US20220186317A1

Chemistry; metallurgy

PREDICTING BREAST CANCER RECURRENCE

#3 | 2021-12-02

US20210371934A1

Chemistry; metallurgy

TUMOR GRADING AND CANCER PROGNOSIS

#4 | 2021-11-18

US20210355550A1

Chemistry; metallurgy

POST-TREATMENT BREAST CANCER PROGNOSIS

#5 | 2020-06-18

US20200190597A1

Chemistry; metallurgy

IDENTIFICATION OF TUMORS

#6 | 2020-03-26

US20200095642A1

Chemistry; metallurgy

GRADING OF BREAST CANCER

#7 | 2018-10-11

US20180291461A1

Chemistry; metallurgy

Tumor grading and cancer prognosis

#8 | 2018-05-17

US20180135131A1

Chemistry; metallurgy

Neuroendocrine tumors

#9 | 2018-05-10

US20180127834A1

Chemistry; metallurgy

PREDICTING BREAST CANCER TREATMENT OUTCOME

#10 | 2018-02-22

US20180051342A1

Chemistry; metallurgy

PROSTATE CANCER SURVIVAL AND RECURRENCE

#11 | 2017-09-07

US20170253931A1

Chemistry; metallurgy

Post-treatment breast cancer prognosis

#12 | 2017-03-16

US20170073767A1

Chemistry; metallurgy

Grading of breast cancer

#13 | 2016-04-28

US20160115556A1

Chemistry; metallurgy

DETECTING MUTATIONS IN DISEASE OVER TIME

#14 | 2015-12-03

US20150344967A1

Chemistry; metallurgy

Predicting likelihood of response to combination therapy

#15 | 2015-12-03

US20150344957A1

Chemistry; metallurgy

MONITORING TREATMENT OF HISTIOCYTOSIS WITH VEMURAFENIB AND DABRAFENIB

#16 | 2015-07-23

US20150203921A1

Chemistry; metallurgy

PREDICTING BREAST CANCER RECURRENCE

#17 | 2015-05-21

US20150139946A1

Chemistry; metallurgy

DETECTING MUTATIONS IN DISEASE OVER TIME

#18 | 2015-05-14

US20150132256A1

Chemistry; metallurgy

DETECTING AND MONITORING MUTATIONS IN HISTIOCYTOSIS

#19 | 2014-11-27

US20140349856A1

Chemistry; metallurgy

Neuroendocrine Tumors

#20 | 2013-10-24

US20130281502A1

Chemistry; metallurgy

POST-TREATMENT BREAST CANCER PROGNOSIS

#21 | 2013-01-24

US20130023441A1

Chemistry; metallurgy

Identification of Tumors

#22 | 2012-12-13

US20120316084A1

Chemistry; metallurgy

Gene expression profiling from FFPE samples

#23 | 2012-09-27

US20120245046A1

Chemistry; metallurgy

Gene expression profiling from FFPE samples

#24 | 2011-07-28

US20110183858A1

Chemistry; metallurgy

GRADING OF BREAST CANCER

#25 | 2011-06-09

US20110136680A1

Chemistry; metallurgy

Tumor grading and cancer prognosis

#26 | 2011-02-10

US20110034346A1

Chemistry; metallurgy

Gene expression profiling from FFPE samples

InventorID:

54423 ⎘